Third Rock Ventures III, L.P. - 02 Feb 2023 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Feb 2023, 15:30:38 UTC
Prior SEC filing
01 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kevin Gillis, Chief Operating Officer of TRV GP III, LLC, general partner of Third Rock Ventures GP III, L.P., general partner of Third Rock Ventures III, L.P.

Key filing fact

Third Rock Ventures III, L.P. filed Form 4 for Voyager Therapeutics, Inc. (VYGR) on 06 Feb 2023.

Key facts

  • This page summarizes Third Rock Ventures III, L.P.'s Form 4 filing for Voyager Therapeutics, Inc. (VYGR).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Feb 2023, 15:30.

Change

  • Previous filing in this sequence was filed on 01 Feb 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VYGR transaction

Common Stock

Other

Transaction value
Shares
-1,500,000
Change %
-32%
Price
Shares after
3,185,291
Date
02 Feb 2023
Ownership
Direct
Footnotes
F1, F2
VYGR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
86,265
Date
02 Feb 2023
Ownership
Direct
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Third Rock Ventures III, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

On February 2, 2023, Third Rock Ventures III, L.P. ("TRV III") distributed, for no consideration, 1,500,000 shares of Common Stock of the Issuer (the "Shares") to its limited partners and to Third Rock Ventures GP III, L.P. ("TRV GP III"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.

Footnote F2

These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual manager of TRV GP III LLC is Dr. Robert Tepper ("Tepper"). Each of TRV GP III, TRV GP III LLC and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.

Footnote F3

The shares are directly held by Tepper. Includes Shares received in the distributions described in footnote (1) above.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .